OppenheimerFunds’s Vitamin Shoppe Inc. VSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$610K Sell
86,717
-20,774
-19% -$122K ﹤0.01% 1289
2018
Q4
$510K Buy
107,491
+47,595
+79% +$357K ﹤0.01% 1368
2018
Q3
$599K Sell
59,896
-41,795
-41% -$431K ﹤0.01% 1361
2018
Q2
$707K Sell
101,691
-53,514
-34% -$292K ﹤0.01% 1276
2018
Q1
$675K Sell
155,205
-39,134
-20% -$171K ﹤0.01% 1256
2017
Q4
$855K Buy
194,339
+42,269
+28% +$186K ﹤0.01% 1235
2017
Q3
$814K Buy
152,070
+70,023
+85% +$541K ﹤0.01% 1266
2017
Q2
$956K Buy
82,047
+31,891
+64% +$470K ﹤0.01% 1193
2017
Q1
$1.01M Buy
50,156
+17,947
+56% +$383K ﹤0.01% 1167
2016
Q4
$765K Buy
32,209
+9,327
+41% +$239K ﹤0.01% 1184
2016
Q3
$614K Buy
22,882
+3,287
+17% +$93.4K ﹤0.01% 1178
2016
Q2
$599K Buy
19,595
+1,864
+11% +$55.2K ﹤0.01% 1161
2016
Q1
$549K Sell
17,731
-2,038
-10% -$61.2K ﹤0.01% 1179
2015
Q4
$646K Buy
+19,769
New +$627K ﹤0.01% 1189

Other funds holding VSI

OppenheimerFunds's VSI Position: Q1 2019 in Review

OppenheimerFunds reduced its Vitamin Shoppe Inc. (VSI) stake by 19% in Q1 2019, selling an estimated $122K and leaving 86,717 shares worth $610K. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

OppenheimerFunds first reported a position in VSI in Q4 2015 and has held it in 14 quarters since. The position peaked at $1.01M in Q1 2017. 124 funds tracked by Wall St. Rank hold VSI as of Q1 2019.

  • OppenheimerFunds held 86,717 shares of Vitamin Shoppe Inc. worth $610K as of Q1 2019.
  • OppenheimerFunds sold 20,774 Vitamin Shoppe Inc. shares in Q1 2019, an estimated $122K.
  • Vitamin Shoppe Inc. made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1289 holding.
  • OppenheimerFunds first reported a position in Vitamin Shoppe Inc. in Q4 2015 and has held it in 14 quarters since.
  • OppenheimerFunds's Vitamin Shoppe Inc. position peaked at $1.01M in Q1 2017.
  • 124 funds tracked by Wall St. Rank held Vitamin Shoppe Inc. as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.